Thandeka Moyo to AIDS Vaccines
This is a "connection" page, showing publications Thandeka Moyo has written about AIDS Vaccines.
Connection Strength
0,629
-
Targeting the N332-supersite of the HIV-1 envelope for vaccine design. Expert Opin Ther Targets. 2020 06; 24(6):499-509.
Score: 0,603
-
Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency. J Virol. 2015 May; 89(10):5264-75.
Score: 0,026